Abbott
Abbott Laboratories is a global healthcare leader that discovers, develops, manufactures, and sells a diversified portfolio of healthcare products. The company operates across the entire care continuum, providing branded generic pharmaceuticals, diagnostic systems, nutritional products, and advanced medical devices. Its core value proposition focuses on improving health outcomes through technological innovation and a broad presence in both developed and emerging markets.
Financials
Based on Q1 2026 filing
Revenue
View metricGross Profit
View metricNet Income
View metricOperating Cash Flow
View metricFree Cash Flow
View metricEPS (Diluted)
View metricBusiness Segments
Medical Devices
primaryFocuses on innovative technologies for cardiovascular health, diabetes care, and neuromodulation. This segment provides life-saving devices for heart failure, rhythm management, and continuous glucose monitoring.
FreeStyle Libre, Lingo, MitraClip, HeartMate, XIENCE, Aveir, Gallant, EnSite, Proclaim, Navitor
Hospitals, Ambulatory surgery centers, Physicians' offices, Consumers, Wholesalers
Established Pharmaceutical Products
majorProvides a broad line of branded generic pharmaceuticals marketed and sold exclusively outside the United States in emerging markets. The segment focuses on building strong brands in therapeutic areas such as gastroenterology, women's health, cardiovascular, and respiratory medicine.
Creon, Duspatal, Dicetel, Heptral, Duphalac, Duphaston, Femoston, Lipanthyl, TriCor, Synthroid, Klacid, Influvac
Wholesalers, Distributors, Government agencies, Healthcare facilities, Pharmacies
Diagnostic Products
majorDevelops and markets diagnostic systems and tests used by hospitals, laboratories, and clinics to screen and diagnose various diseases. The portfolio includes core laboratory, molecular, point-of-care, and rapid diagnostic solutions.
Alinity, ARCHITECT, Cell-Dyn, BinaxNOW, Panbio, ID NOW, i-STAT, Vysis FISH, Afinion, AlinIQ
Blood banks, Hospitals, Commercial laboratories, Physicians' offices, Plasma protein therapeutic companies
Nutritional Products
majorManufactures and markets pediatric and adult nutritional products designed to support health and wellness. This segment includes infant formulas and specialized medical nutrition for enteral feeding in healthcare settings.
Similac, Ensure, Glucerna, PediaSure, Pedialyte, EleCare, Jevity, Nepro, Vital
Consumers, Institutions, Wholesalers, Retailers, Healthcare facilities
Segment Financials
Medical Devices — Total Assets
View metricMedical Devices — Increase (decrease) in in-process research and development assets
View metricDiagnostic Products — Total Assets
View metricEstablished Pharmaceuticals — Total Assets
View metricNutritional Products — Total Assets
View metricBusiness Overview
Competitive Position
Abbott is a diversified healthcare leader with dominant positions in continuous glucose monitoring and pediatric nutrition, competing through high-tech innovation and brand equity.
Geographies
Global, United States, Emerging Markets
Customer Segments
Healthcare Providers, Government Agencies, Retail Consumers, Laboratories
Upstream Dependencies
Raw material suppliers, Specialized component manufacturers, Biopharmaceutical R&D partners, Third-party logistics providers
Downstream Customers
Hospitals and health systems, Retail pharmacies and grocery chains, Government health departments, Individual patients and consumers
Competitors & Partners
Competitors
Medtronic
MDT
Competitor in medical devices and rhythm management
Johnson & Johnson
JNJ
Competitor in medical devices and consumer health
Becton, Dickinson and Company
BDX
Competitor in medical devices and diagnostics
Boston Scientific
BSX
Competitor in cardiovascular and neuromodulation markets
Edwards Lifesciences
EW
Competitor in transcatheter mitral and tricuspid repair technologies.
DexCom
DXCM
Competitor in continuous glucose monitoring
Abbott FAQ
Common questions about Abbott
Abbott Laboratories is a global healthcare leader that discovers, develops, manufactures, and sells a diversified portfolio of healthcare products. The company operates across the entire care continuum, providing branded generic pharmaceuticals, diagnostic systems, nutritional products, and advanced medical devices. Its core value proposition focuses on improving health outcomes through technological innovation and a broad presence in both developed and emerging markets.
Abbott (ABT) has a market capitalization of $152.88B and trades on NYSE.
Abbott generated $45.1B in trailing twelve-month revenue with net income of $6.3B, representing a net margin of 13.9%. Gross margin stands at 56.3%, with free cash flow of $7.4B. These figures are based on the Q1 2026 filing.
Abbott's key competitors include Medtronic, Johnson & Johnson, Becton, Dickinson and Co., and others. These companies compete in similar markets and product categories.
Abbott has approximately 114,000 employees.